T28353 |
PDP-EA
|
861891-72-7
|
98%
|
|
PDP-EA is an activator of fatty acid amide hydrolase(FAAH) and enhances the amidohydrolase activity of FAAH.
|
T67896 |
CB2R/FAAH modulator-1
|
928892-60-8
|
100%
|
|
CB2R/FAAH modulator-1, a cannabinoid type 2 receptor (CB2R) agonist, is also a fatty acid amide hydrolase (FAAH) inhibitor (IC50=4 μM) that reduces the productio...
|
T23119 |
Palmitoylisopropylamide
|
189939-61-5
|
100%
|
|
Palmitoylisopropylamide is a selective FAAH inhibitor that inhibits [H]-AEA uptake and cell proliferation at low concentrations.
|
T4323 |
PF-04457845
|
1020315-31-4
|
100%
|
|
PF-04457845 is a greatly and effctive FAAH inhibitor, and for hFAAH(IC50=7.2±0.63 nM) and rFAAH(IC50=7.4±0.62 nM).
|
T28076 |
MM-433593
|
1006604-91-6
|
100%
|
|
MM-433593 is a selective fatty acid amide hydrolase (FAAH-1) inhibitor for the treatment of pain, inflammation, and other disorders.
|
T2859 |
Biochanin A
|
491-80-5
|
97.1%
|
|
Biochanin A (4-Methylgenistein) is an isoflavone derivative isolated from red clover Trifolium pratense with anticarcinogenic properties. Biochanin A is a natura...
|
T6714 |
URB-597
|
546141-08-6
|
97.84%
|
|
URB-597 (FAAH Inhibitor II) is an effective, orally bioavailable FAAH inhibitor (IC50: 4.6 nM), and no effect on other cannabinoid-related targets.
|
T6043 |
PF-3845
|
1196109-52-0
|
98%
|
|
PF-3845 is a potent, selective and irreversible FAAH inhibitor with Ki of 230 nM, showing negligible activity against FAAH2.
|
T11256 |
FAAH inhibitor 1
|
326866-17-5
|
98.05%
|
|
FAAH inhibitor 1 (Benzothiazole analog 3) is an effective FAAH inhibitor with an IC50 of 18 nM.
|
T15802 |
LY2183240
|
874902-19-9
|
98.17%
|
|
LY2183240 inhibits fatty acid amide hydrolase (FAAH) activity (IC50 = 12.4 nM). LY2183240 is a novel and highly effective blocker of anandamide uptake (IC50 = 27...
|
T5357 |
ARN272
|
488793-85-7
|
98.23%
|
|
ARN272 is a FAAH-like anandamide transporter (FLAT) inhibitor (IC50: 1.8 μM).
|
T68492 |
AM 374
|
86855-26-7
|
98.39%
|
|
AM 374 (HDSF), a fatty acid amide hydrolase (FAAH) inhibitor, demonstrates the capacity to inhibit amidase activity, boasting an IC50 value of 13 nM. This compou...
|
T16515 |
PF 750
|
959151-50-9
|
98.83%
|
|
PF 750 (ZINC27647189) is a selective and covalent inhibitor of FAAH. PF 750 shows IC50s varying from 16.2 to 595 nM in different incubation times.
|
T67747 |
CB2R/FAAH modulator-3
|
2876918-67-9
|
99.02%
|
|
CB2R/FAAH modulator-3 (compound 27) is a modulator targeting at CB2R and FAAH. CB2R/FAAH modulator-3 acts as a CB2R agonist and FAAH inhibitor, the Ki values are...
|
T7688 |
4-Nonylphenylboronic acid
|
256383-45-6
|
99.13%
|
|
4-Nonylphenylboronic acid is a inhibitor of FAAH.
|
T15268 |
FAAH-IN-2
|
184475-71-6
|
99.18%
|
|
FAAH-IN-2 (O-Desmorpholinopropyl Gefitinib) is a potent inhibitor of FAAH(fatty acid amide hydrolase).
|
T77594 |
VU534
|
923509-20-0
|
99.22%
|
|
VU534 is a NAPE-PLD agonist with an EC50 of 0.30 μM.VU534 is a dual inhibitor of FAAH and sEH, with an IC50 of 1.2 μM for sEH.VU534 is used in diseases related t...
|
T77513 |
2-Chlorophenylboronic acid
|
3900-89-8
|
99.42%
|
|
2-Chlorophenylboronic acid is a monohalogenated phenylboronic acid, which is an important pharmaceutical intermediate and is widely used in the synthesis of new ...
|
T1325 |
Carprofen
|
53716-49-7
|
99.45%
|
|
Carprofen (Ridamyl) is a propionic acid derivate and nonsteroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic activities.
|
T67745 |
CB2R/FAAH modulator-2
|
2876918-68-0
|
99.52%
|
|
CB2R/FAAH modulator-2 (compound 26) is a dual modulator targeting at CB2R and FAAH. CB2R/FAAH modulator-2 acts as a CB2R agonist and FAAH inhibitor, the Ki value...
|